Using Mental Imagination to Prevent Excessive Gestational Weight Gain in Overweight and Obese Pregnant Women
MAWI
1 other identifier
interventional
70
1 country
1
Brief Summary
Moms Are Worth It is a lifestyle behavior intervention study aims to prevent excessive gestational weight gain in overweight or obese pregnant women through promotion of the stress management, healthy eating, and physical activity. Eligible women will be randomly assigned to a usual care or an intervention plus usual care group. The intervention will last 20 weeks and will be delivered via weekly web and individual health coaching session (10 of them)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started Feb 2021
Typical duration for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 19, 2020
CompletedFirst Posted
Study publicly available on registry
November 10, 2020
CompletedStudy Start
First participant enrolled
February 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2023
CompletedResults Posted
Study results publicly available
January 3, 2025
CompletedJanuary 3, 2025
November 1, 2024
2 years
October 19, 2020
August 10, 2023
November 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Percent Change in Body Weight
Data extracted from electronic medical record
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Percent Change in Body Weight
Data extracted from electronic medical record
24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Percent Change in Body Weight
Data extracted from electronic medical record
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Secondary Outcomes (37)
Percentage of Participants Diagnosed With Gestational Diabetes
24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Percentage of Participants Diagnosed With Gestational Hypertension
24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Percentage of Participants With Cesarean Delivery
35-37 week-gestation (T3)
Newborn Body Weight
35-37 week-gestation (T3)
Percentage of Participants With Premature (<37 Weeks Gestation) Births
35-37 week-gestation (T3)
- +32 more secondary outcomes
Study Arms (2)
Goal-Oriented Episodic Future Thinking (GOEFT) Intervention
EXPERIMENTALIn addition to usual prenatal care, intervention participants will receive a 20-week intervention via web and individual health counseling. The intervention topics focus on stress management, healthy eating, and physical activity.
Usual Prenatal Care
NO INTERVENTIONThe usual prenatal care group will receive usual care from their providers
Interventions
Individuals in the intervention group will receive a 20-week web-based intervention and individual health coaching focused on stress management, healthy eating and physical activity.
Eligibility Criteria
You may qualify if:
- Participants must be pregnant women ≤ 13 week-gestation with a single fetus as assessed by ultrasound.
- Participants must also have self-reported pre-pregnancy body mass index (BMI) of 25.0-45.0 kg/m2 and height (height and weight to compute body mass index).
- Ability to read and speak English,
- Age of 18-45 years,
- Access to a working smart phone with unlimited text messaging,
- Access to internet,
- Receipt of prenatal care from our collaborating clinics and plan to deliver the baby at The Ohio State University (OSU) Wexner Medical Center,
- Resident of Franklin Count,
- Committed to the 20-week intervention.
You may not qualify if:
- Self-reported history of ≥ 3 miscarriages,
- Planned termination of the pregnancy,
- Diagnosed hypertension and/or type 1 or 2 diabetes,
- History of or current diagnosis of an eating disorder,
- Serious current physical disease (e.g., renal disease or cancer),
- Past bariatric surgery,
- Current or history of substance abuse in the past 6 months,
- Current treatment for a serious psychological disorder (e.g., schizophrenia and bipolar disorder),
- Contraindications to walking,
- Consented women will become not eligible to participate in the study if they are not randomized by 16-week 6 days gestation. This is because the study intervention starts ≤ 17 weeks gestation.
- Women will become not ineligible for participation if they did not complete the baseline data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Ohio State University
Columbus, Ohio, 43210, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Mei-Wei Chang, PhD
- Organization
- Ohio State University College of Nursing
Study Officials
- PRINCIPAL INVESTIGATOR
Mei-Wei Chang, PhD
Ohio State University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoicate Professor
Study Record Dates
First Submitted
October 19, 2020
First Posted
November 10, 2020
Study Start
February 1, 2021
Primary Completion
January 30, 2023
Study Completion
December 30, 2023
Last Updated
January 3, 2025
Results First Posted
January 3, 2025
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share